Association of Cumulative Social Risk and Cancer-Specific Survival Among Patients With Advanced Colorectal Cancer [0.03%]
累积社会风险与晚期结直肠癌患者癌症特异性生存率的关系
Kirbi Yelorda,Heather Day,M Katherine Arnow et al.
Kirbi Yelorda et al.
Objective: To examine associations of individual and cumulative multiple, co-occurring individual-level social risk factors with long-term cancer-specific survival among patients with advanced colorectal cancer....Conclusion: Cumulative social risk was associated with long-term cancer-specific survival after treatment for Stage III colorectal cancer.
Prognostic significance of the pretreatment controlling nutritional status score in colorectal cancer patients: an updated meta-analysis with 24 cohort studies [0.03%]
术前营养状况评分对结直肠癌患者预后影响的meta分析研究
Jingkun Shang,Jinlai Wei
Jingkun Shang
exhibited significantly poorer outcomes across multiple survival metrics: overall survival (HR = 1.73; 95%CI: 1.50-2.01; P < 0.01; I 2 = 62%), recurrence-free survival (HR = 1.51; 95% CI: 1.22-1.87; P < 0.01; I 2 = 14%), disease-free survival (HR = 1.61; 95% CI: 1.33-1.95; P < 0.01; I 2 = 35%), and cancer-specific...survival (HR = 3.94; 95% CI: 2.34-6.62; P < 0.01; I 2 = 0%).
Predictive role of circulating tumor DNA based molecular residual disease for long-term outcomes in non-small cell lung cancer patients: a meta-analysis [0.03%]
循环肿瘤DNA介导的分子残留病灶对非小细胞肺癌患者长期结局预测作用的 meta 分析
Siyuan Che,Dongliang Yu
Siyuan Che
The primary outcome was progression-free survival (PFS), and the secondary outcomes included overall survival (OS) and cancer-specific survival (CSS).
Oncologic and renal function outcomes of segmental ureterectomy vs. radical nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis [0.03%]
上尿路尿路上皮癌部分性输尿管切除术与根治性肾输尿管切除术的肿瘤学和肾脏功能结局:系统评价和Meta分析
Alejandro Calvillo-Ramirez,Lauren Chew,Laura Davis et al.
Alejandro Calvillo-Ramirez et al.
Primary outcomes were cancer-specific survival (CSS), estimated glomerular filtration rate (eGFR) changes, and postoperative eGFR. Secondary outcomes included overall survival (OS), recurrence-free survival (RFS), and metastasis-free survival (MFS).
Prognostic Role of Serum IL-6 Levels in Bladder Cancer Patients and Hints of its Origin [0.03%]
血清IL-6水平对膀胱癌患者的预后作用及其来源线索
Simon U Engelmann,Christoph Pickl,Maximilian Haas et al.
Simon U Engelmann et al.
In bladder cancer (BC) patients, higher IL-6 serum levels have been linked with adverse pathologic features, worse overall survival (OS) and cancer-specific survival (CSS). IL-6 is being investigated as a therapeutic target. However, concentrations in tumor-tissue are not investigated in detail.
Cancer-Specific Survival of Trimodal Therapy Versus Radical Cystectomy in T2N0M0 Non-Urothelial Bladder Cancer [0.03%]
T2N0M0期非尿路上皮膀胱癌三联疗法与根治性膀胱切除术的肿瘤特异性生存率比较
Mattia Longoni,Andrea Marmiroli,Fabian Falkenbach et al.
Mattia Longoni et al.
Introduction: We hypothesized that, within organ-confined (OC, T2N0M0) non-urothelial carcinoma of urinary bladder (non-UCUB) patients, trimodal therapy (TMT) use does not differ from radical cystectomy (RC) regarding can...
Clinical Comparison Between Curative and Non-Curative Treatment for Hepatocellular Carcinoma with Hepatic Vein Invasion: A Nationwide Cohort Study [0.03%]
一项全国队列研究:可切除与不可切除的肝静脉癌栓肝细胞癌治疗结局的临床分析
Sehyeon Yu,Hye-Sung Jo,Young-Dong Yu et al.
Sehyeon Yu et al.
In long-term outcomes, the overall survival (OS) and cancer-specific survival (CSS) were significantly better in the curative group compared to the non-curative group (p < 0.001, both).
Ruisheng Huang,Jian Chen,Limin Lin et al.
Ruisheng Huang et al.
Objective: To develop a nomogram that accurately predicts cancer-specific survival (CSS) in patients with ocular melanoma (OM)....Conclusion: We developed a nomogram that can be used to predict the 3, 5 and 8 years cancer-specific survival (CSS) rates for patients diagnosed with OM.
Long-Term Outcomes of Multimodality Accelerated Partial Breast Irradiation for Ductal Carcinoma In Situ [0.03%]
多模态部分乳腺照射治疗导管原位癌的长期预后
Silpa Raju-Salicki,Hayley B Stowe,Alden DSouza et al.
Silpa Raju-Salicki et al.
Breast cancer-specific survival (BCSS) was 99.6% at the time of analysis. There was no statistically significant difference in overall survival or recurrence rates between the different treatment modalities.
High visceral-to-subcutaneous fat area ratio is an unfavorable prognostic indicator in patients with uterine sarcoma [0.03%]
子宫肉瘤患者中较高的内脏脂肪与皮下脂肪面积比为不良预后指标
Mariko Kurokawa,Wataru Gonoi,Shouhei Hanaoka et al.
Mariko Kurokawa et al.
The effects of body composition parameters and clinical data on overall survival (OS) and cancer-specific survival (CSS) were analyzed.
耗时 0.14566 秒,为您在
48229835
条记录里面共找到 9581 篇文章 [XML]